61Indexed trials
Market Rank #31 · Evidence Tier A
Greece
Neuroscience Intelligence
Greece neuroscience intelligence: 61 indexed trials, 19 institutions, research score 29.16.
27Recruiting
19Research institutions
29.2Research score
Evidence profile
40Sponsors
18Disease areas
0Institution works
0Institution citations
Model signals
Opportunity 29 · ML priority 29 · Confidence 85 · Evidence 29.2
These are comparative evidence signals. They do not represent a guarantee of market size or commercial outcome.
Leading disease areas
parkinsons9trials
alzheimers8trials
epilepsy6trials
multiple_sclerosis6trials
schizophrenia3trials
stroke3trials
autism2trials
depression2trials
other_psychiatry2trials
migraine_headache1trials
Leading indexed sponsors
Merck Sharp & Dohme LLC8trials
Novo Nordisk A/S4trials
Aristotle University Of Thessaloniki3trials
National and Kapodistrian University of Athens3trials
Hoffmann-La Roche2trials
Attikon Hospital2trials
Boehringer Ingelheim2trials
AbbVie2trials
Bayer2trials
Eli Lilly and Company2trials